Stillbirth and late pregnancy loss
Nine babies are stillborn every day in the UK. We’re funding vital studies to understand the conditions that can cause stillbirth and late miscarriage, and identify how they can be prevented.

Following our landmark research on the microbiome, we are now aiming to fund development of a targeted antibiotic and probiotic treatment that can change the profile of bacteria in the reproductive tract and reduce the risk of miscarriage, stillbirth, ectopic pregnancy and preterm birth.

Research Achievements

Our research identified severe obstetric cholestasis – also known as intrahepatic cholestasis of pregnancy (ICP) and associated with increased bile acids in a pregnant woman’s bloodstream – trebles the risk of stillbirth and developed an inexpensive blood test to assess this risk. This International Stillbirth Alliance reports a “need to speed up work to reduce stillbirth”. We are behind this drive.

 

Support our research!

We rely on supporters to keep our research going! You can join our friendly fundraisers on a cycling or trekking challenge! or make a direct donation!